Evidence map›Paper›PMID 29232479›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2018

Metabolomic Pathways to Osteoporosis in Middle-Aged Women: A Genome-Metabolome-Wide Mendelian Randomization Study.

Alireza Moayyeri, Ching-Lung Cheung, Kathryn Cb Tan, John A Morris, Agustin Cerani, Robert P Mohney, J Brent Richards, Christopher Hammond, Tim D Spector, Cristina Menni

Open access · hybridAbstract readTwin Study
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Low Circulating Valine Associate With High Risk of Hip Fractures.The Journal of clinical endocrinology and metabolism · 2023
    Pooled it
  2. Metabolomic biomarkers of low BMD: a systematic review.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 5 countries.

Alireza MoayyeriDepartment of Twin Research & Genetic Epidemiology, King's College London, London, UK.
Ching-Lung CheungState Key Lab of Pharmaceutical Biotechnology, Hong Kong, China.
Kathryn Cb TanDepartment of Medicine, University of Hong Kong, Pokfulam, Hong Kong, China.
John A MorrisDepartment of Human Genetics, McGill University, Montreal, Canada.
Agustin CeraniCentre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Canada.
Robert P MohneyMetabolon, Inc., Durham, NC, USA.
J Brent RichardsDepartment of Twin Research & Genetic Epidemiology, King's College London, London, UK.
Christopher HammondDepartment of Twin Research & Genetic Epidemiology, King's College London, London, UK.
Tim D SpectorDepartment of Twin Research & Genetic Epidemiology, King's College London, London, UK.
Cristina MenniDepartment of Twin Research & Genetic Epidemiology, King's College London, London, UK.
King's College London · GBJewish General Hospital · CAMcGill Genome Centre · CAMetabolon (United States) · USPharmaceutical Biotechnology (Czechia) · CZUniversity College London · GBUniversity of Hong Kong · HK

Funding

Medical Research Council MR/M004422/1Medical Research Council MR/M016560/1Wellcome Trust
6 · The paper itself

Abstract

The metabolic state of the body can be a major determinant of bone health. We used a Mendelian randomization approach to identify metabolites causally associated with bone mass to better understand the biological mechanisms of osteoporosis. We tested bone phenotypes (femoral neck, total hip, and lumbar spine bone mineral density [BMD]) for association with 280 fasting blood metabolites in 6055 women from TwinsUK cohort with genomewide genotyping scans. Causal associations between metabolites and bone phenotypes were further assessed in a bidirectional Mendelian randomization study using genetic markers/scores as instrumental variables. Significant associations were replicated in 624 participants from the Hong Kong Osteoporosis Study (HKOS). Fifteen metabolites showed direct associations with bone phenotypes after adjusting for covariates and multiple testing. Using genetic instruments, four of these metabolites were found to be causally associated with hip or spine BMD. These included androsterone sulfate, epiandrosterone sulfate, 5alpha-androstan-3beta17beta-diol disulfate (encoded by CYP3A5), and 4-androsten-3beta17beta-diol disulfate (encoded by SULT2A1). In the HKOS population, all four metabolites showed significant associations with hip and spine BMD in the expected directions. No causal reverse association between BMD and any of the metabolites were found. In the first metabolome-genomewide Mendelian randomization study of human bone mineral density, we identified four novel biomarkers causally associated with BMD. Our findings reveal novel biological pathways involved in the pathogenesis of osteoporosis. © 2017 American Society for Bone and Mineral Research.

Indexed as

Mendelian Randomization AnalysisAdultAgedBone DensityCytochrome P-450 CYP3AFemaleHumansMetabolomeMiddle AgedOsteoporosisSulfotransferasesalcohol sulfotransferaseCYP3A5 protein, humanCytochrome P-450 CYP3ASulfotransferasesBONE MINERAL DENSITYGENOMEWIDE ASSOCIATION STUDIESINSTRUMENTAL VARIABLES ANALYSISMENDELIAN RANDOMIZATIONMETABOLOMICSOSTEOPOROSIS

Identifiers

PMID29232479
PMCPMC5972819
OpenAlexW2771227656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.